Ä¢¹½ÊÓƵAPP

Michael Wong is the Director of Business Development and Strategy at Ä¢¹½ÊÓƵAPP. He joined Flagship in 2019, where he first worked in venture creation to build, lead, and scale four biotech companies across AI/ML drug discovery, degenerative disease, cell therapy, and nucleic acid delivery. As a passionate company builder and scientist, Michael leverages his expertise in platform technologies and early-stage strategy and operations to drive valuable business development and partnership opportunities between Flagship’s portfolio companies and the biopharma industry.

Prior to Flagship, Michael was the co-founder and CEO of ARCHITECHealth, a life sciences firm that provided strategy, data research, and competitive intelligence for biopharma, healthcare organizations, and investors. He was also the founder of a software and technology startup, and the founding director of Industry Link, an organization dedicated to training future entrepreneurial scientists.

Michael earned his Ph.D. in Medical Sciences from McMaster University and his M.Sc. and B.Sc. in Physiology and Pharmacology from Western University, where he engineered 3D cellular models of the human placenta and investigated the impact of drug and toxin exposure on maternal-fetal health and development. His work resulted in over a dozen publications and patents. He was also a Vanier Scholar, where he nationally ranked as one of the top four doctoral scientists by the Canadian Institutes of Health Research.